rheumatoid arthritis. Rheumatoid arthritis with rheumatoid factor
Conditions
Interventions
Intervention 1: The intervention group received a 500 mg capsule (A package) every 12 hours for 30 days. Intervention 2: Control group: The placebo group received a 500 mg capsule (B package) for 30 d
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
36 Years to 55 Years
Inclusion criteria
Inclusion criteria: Having a diagnosis of rheumatoid arthritis by a doctor at least 6 months ago, Medical records referring to rheumatology clinics of Tehran rheumatology center of Iran. People aged 25 to 65 years There was no injury, open wounds and fractures in painful areas and joints, Willingness to participatein research. Not using other therapies such as hydrotherapy, thermotherapy, acupuncture
Exclusion criteria
Exclusion criteria: Unwillingness to continue cooperation in research. Patients who did not have good cooperation, did not take medication properly or did not have regular follow-up. Due to much pain, consuming medication or intra-articular injection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severe pain in joints. Timepoint: Before the intervention and 30 days after taking the medication. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life Score. Timepoint: Quality of Life / Before the start of the study and one month after the start of the study. Method of measurement: Questionnaire with 24 questions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Zaferani Arani
Islamic Azad University
Outcome results
None listed